Table: Phoenixbio -2022/23 parent results
May 15 (Reuters)-
Phoenixbio Co., Ltd.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 2.12 1.32
(+60.3 pct)
Operating 410 mln loss 199 mln
Recurring 413 mln loss 160 mln
Net 397 mln loss 163 mln
EPS 116.92 yen loss 49.43 yen
EPS Diluted 78.32 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Phoenixbio Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T